HK Stock MarketDetailed Quotes

CHINARES PHARMA (03320)

Watchlist
  • 5.010
  • -0.050-0.99%
Market Closed May 14 16:07 CST
31.48BMarket Cap7.03P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CHINARES PHARMA (03320) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
Distribution division212.06B78.66%
Manufacturing branch45.21B16.77%
Retail branch12.21B4.53%
Other93.25M0.03%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Distribution division212.06B78.66%
Manufacturing branch45.21B16.77%
Retail branch12.21B4.53%
Other93.25M0.03%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
The mainland of China268.51B99.60%
Other1.07B0.40%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.66%
Sample Name
Sample Code
 +3.21%
Sample Name
Sample Code
 +1.57%
4
SINOPEC CORP
00386
+0.66%
5
CNOOC
00883
+0.53%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +47.30%
Sample Name
Sample Code
 +42.24%
Sample Name
Sample Code
 +30.17%
4
Loongson Technology Corporation
688047
+19.58%
5
Digital China Group
000034
+16.92%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -